Keller, U.. (1990) Medikamente gegen Übergewicht. Therapeutische Umschau, Bd. 47, H. 8. pp. 658-663.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6419938
Downloads: Statistics Overview
Abstract
The position of pharmacotherapy of obesity is still controversial. Different groups of drugs are currently available in Switzerland-none is covered by the health insurances. Apparently the authorities are not convinced of their efficacy. Various groups of drugs have been tried, such as amphetamine derivatives, adrenergic drugs, serotonin agonists or hormones with thermogenic effects, intestinal enzyme inhibitors and dietary fibres. The results of sympathomimetic drugs demonstrate a relatively high incidence of side-effects, and with some preparations there is also the risk of addiction. The serotoninergic drug fenfluramine has been demonstrated in several controlled studies to be an effective weight-reducing agent; however, its effect was relatively modest: It lasted only as long as the drug was taken. Fenfluramine is relatively free of side-effects and is reported to diminish `carbohydrate craving`.
Faculties and Departments: | 03 Faculty of Medicine > Departement Biomedizin > Former Units at DBM > Metabolism (Keller/Müller) 03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Ehemalige Einheiten Medizinische Fächer (Klinik) > Klinische Endokrinologie (Keller) 03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Ehemalige Einheiten Medizinische Fächer (Klinik) > Klinische Endokrinologie (Keller) |
---|---|
UniBasel Contributors: | Keller, Ulrich O. |
Item Type: | Article |
Article Subtype: | Research Article |
Publisher: | Hans Huber |
ISSN: | 0040-5930 |
Note: | Variant title: [Drugs against obesity] -- Publication type according to Uni Basel Research Database: Journal article |
Last Modified: | 04 Sep 2015 14:32 |
Deposited On: | 04 Sep 2015 14:32 |
Repository Staff Only: item control page